Hospital Research Teams

The Stephen Solomon Lab

Share
Back to top

Research

Stephen Solomon
Stephen Solomon, MD

Our lab develops new minimally invasive image-guided cancer treatments:

  • Methods for improving the anti-tumor immune response after embolization or ablation.
  • Genetic, imaging, and other tests to predict response after embolization or ablation.
  • New devices for endoluminal ablation (ureter, bile ducts, bronchi, bowel).
  • New intra-arterial therapies for liver and pancreatic cancer.
  • Transgenic pig model for liver and pancreatic cancer.
  • Imaging technologies for rapid diagnosis from biopsy specimens.
  • Outcomes after cancer interventions.
  • Evidence-based cancer imaging.

View Lab Overview

The Stephen Solomon Lab

People

Stephen Solomon

Stephen Solomon, MD

  • Dr. Solomon is an interventional radiologist whose team investigates novel minimally invasive, image-guided therapies and their biologic and immunologic interactions.
View physician profile
Physician profile

Members

Joseph Erinjeri
Constantinos Sofocleous
Constantinos Sofocleous

Collaborator

Stephen B. Solomon
Hooman Yarmohammadi
Etay Ziv
Lab Alumni
Govind Srimathveeravalli
Lab Affiliations

Achievements

  • Thompson family foundation grant. (Drs. Yarmohammadi, Srimathveeravalli, and Boas, in collaboration with David Kelsen, Avigdor Scherz, and others)
  • Department of Defense, Peer Reviewed Cancer Research Program grant (Drs. Solomon, Brown, and Boas, in collaboration with Drs. Schook and Gaba at the University of Illinois)
  • RSNA Research Scholar grant (Dr Yarmohammadi)
  • Ernest J Ring Career Development Grant award from the Society of Interventional Radiology (Dr Yarmohammadi)
  • Ernest J Ring Career Development Grant award from the Society of Interventional Radiology (Dr Srimathveeravalli)
Read more
  • RSNA Research Seed grant (Dr Ziv)
  • SIR Pilot Research grant (Dr Ziv)
  • Society of Interventional Oncology: Interventional oncology/immuno-oncology research grant (Dr Erinjeri)
  • Fulbright Specialist Program Award (Dr Durack)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Biomedical Engineer

Apply now

Interventional Radiology Research Fellow

Apply now

Postdoctoral fellowship position: Quantitative discipline

Apply now

View All Open Positions

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Stephen Solomon discloses the following relationships and financial interests:

  • Adgero Biopharmaceuticals Inc
    Equity
  • Advantagene, Inc.
    Professional Services and Activities
  • Aperture Medical Technology
    Equity; Fiduciary Role / Position; Intellectual Property Rights
  • Aspire Bariatrics
    Equity
  • EndoWays
    Equity
  • GE Healthcare
    Professional Services and Activities
  • Impulse Dynamics
    Equity
  • Innoblative Designs
    Equity
  • Johnson & Johnson
    Equity
  • Lantheus Medical Imaging, Inc.
    Equity
  • Microbot Medical Ltd.
    Professional Services and Activities
  • Motus GI Holdings, Inc.
    Equity
  • Olympus
    Professional Services and Activities
  • Poseida Therapeutics, Inc.
    Equity
  • SureFire, LLC
    Equity
  • Varian Medical Systems
    Professional Services and Activities
  • XACT Robotics, Ltd.
    Professional Services and Activities (Uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures